Brought to you by www.DealSearchOnline.com
July 7, 2014 Issue:
Recent Health Care M&A Deals
Assets from Healthfirst
Health Plan of New Jersey, Inc.
Small Bone Innovations, Inc.
Phase 2 oncology drug
Transcept Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc.
The Eyes Have It for CooperVision
The Cooper Companies, Inc. (NYSE: COO) last week announced it will pay $1.2 billion for Sauflon Pharmaceuticals Ltd., the privately owned British soft contact lens and solutions maker. It will be combined with its CooperVision business unit, which can now offer a multi-tier daily strategy for contacts wearers. Sauflon has three manufacturing plants, sales offices in more than 10 countries, and products sold in more than 50 countries…………Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Health Care M&A Picks Up in June
Summer has just begun, but June was a hot month for health care mergers and acquisitions. Total deal volume now stands at 106 transactions, with a combined total of $51.3 billion. The services sector slowed slightly, but the technology sectors took off. We’re comparing last month’s preliminary results with solid data from a year ago, so more deals could be added to the June 2014 total.
Deal Volume by Sector, June 2014 vs. June 2013
Behavioral Health Care
Home Health & Hospice
Labs, MRI & Dialysis
Physician Medical Groups
Source: The Health Care M&A News, June 2014
Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today
ViraCor-IBT Laboratories Changes Hands
Ampersand Capital Partners completed the sale of majority owned portfolio company ViraCor-IBT Laboratories (VIBT) to Eurofins Scientific for $255 million. VIBT is a specialty testing laboratory that was created by Ampersand in 2009 through the merger of two independent labs in the Kansas City area……….Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
Cidara Therapeutics Raises $32 Million Series A Financing
San Diego-based Cidara Therapeutics, Inc. is now able to advance candidates from its CloudBreak™ targeted immunotherapy platform and biafungin™, a novel long-acting echinocandin antifungal drug, into human clinical studies. The announcement came as a result of its successful $32 million Series A financing round, led by 5AM Ventures, Aisling Capital, Frazier Healthcare and InterWest Partners, as well as select institutional cross over investors………Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.
American Society of Appraisers Healthcare Conference, Sept. 12-13, Savannah, GA
A blockbuster faculty lineup has been announced for this in-person healthcare valuation conference. The Four Pillars of the Healthcare Industry: A Review of the Reimbursement, Regulatory, Competitive, and Technological Environment for Healthcare Valuation. Register online or (800) 272-8258.
The 2014 Hospital Acquisition Report 2 for 1 Special – Preorder Today!
There’s no quicker way to get current on the hospital M&A market or review historic hospital M&A data. Learn all about today’s hospital merger and acquisition market, not just what’s covered in major media.Take advantage of our limited time two-for-one offer: Order by July 31st and receive the 2013 Edition for FREE! Go to http://www.levinassociates.com/hospital-description or call 800-248-1668 to order today.
Around the Web in Health Care M&A…Click here to see more
Webcast Calendar…Click here to see more
Upcoming Conference Partnerships… Click here to see more
Previous Issues of Health Care Deal News…Click here to see more